Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -1027.9% | n/a |
ROCE | 4172.7% |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 23.9 | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | -84.0% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-21 | 0.32 | (5.90) | (3.05)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-22 | 0.62 | (5.57) | (2.65)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-23 | 0.08 | (4.26) | (1.75)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-24 | 1.91 | (3.01) | (0.87)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-25 | 0.31 | (3.29) | (0.65)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Holding(s) in Company | 01-Oct-2025 | 17:21 | RNS |
Issue of Equity | 26-Sep-2025 | 07:00 | RNS |
REPLACEMENT-Chill Brands appointed UK Distributor | 19-Sep-2025 | 13:30 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 1.43p |
Change Today | 0.033p |
% Change | 2.38 % |
52 Week High | 2.15 |
52 Week Low | 1.10 |
Volume | 128,063 |
Shares Issued | 522.93m |
Market Cap | £7.50m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
14:11 | 115 @ 1.30p |
12:46 | 2,551 @ 1.30p |
10:12 | 55 @ 1.50p |
10:12 | 55 @ 1.30p |
10:12 | 48 @ 1.50p |
You are here: research